1. Herpes Simplex virus type 2 seroprevalence and risk factors among adolescents and youth with HIV-1 in Northern, Tanzania.
- Author
-
Madebe R, Kiwelu I, Ndaro A, Francis F, Baraka V, Theilgaard Z, and Katzenstein T
- Subjects
- Adolescent, Child, Cross-Sectional Studies, Female, HIV Infections virology, Humans, Male, Risk Factors, Seroepidemiologic Studies, Sexual Behavior, Tanzania epidemiology, Young Adult, Antibodies, Viral blood, HIV Infections epidemiology, Herpes Genitalis epidemiology, Herpes Genitalis immunology, Herpesvirus 2, Human immunology
- Abstract
Introduction: Herpes Simplex virus type 2 (HSV-2) infection is associated with an increased risk of human immunodeficiency virus type 1 (HIV-1) acquisition and transmission. Individuals co-infected with HIV-1 and HSV-2 may have longer lasting, more frequent and severe outbreaks of herpes symptoms. Previous studies have assessed HSV-2 seroprevalence and associated risk factors in adult populations. However, there is limited data on the HSV-2 seroprevalence among adolescents and youth living with HIV-1. The study aimed to determine the HSV-2 seroprevalence and associated risk factors among adolescents and youth living with HIV-1 at referral hospital setting in Northern Tanzania., Methodology: A cross-sectional survey was conducted between February and July 2017 among HIV-1-infected individuals aged 10-24 years attending the Child -Centred Family Care Clinic at Kilimanjaro Christian Medical Centre. Blood specimens from 180 individuals were collected for ELISA-based detection of HSV-2 antibodies. Associations between risk factors and HSV-2 seroprevalence were analysed by univariate and multivariate logistic regression models., Results: The overall HSV-2 seroprevalence was 18% (32/180). A significant HSV-2 seroprevalence was noted among adolescents and youth, who reported having had sexual intercourse than those who never had sexual intercourse (28.9% vs 13.3%, p = 0.02). Youths aged 20-24 had six folds higher risk of HSV-2 seroprevalence compared to those aged 10-14 years (AOR = 5.97 95% CI 1.31 - 27.19, p = 0.02)., Conclusions: Our study found that HSV-2 seroprevalence increased by age among adolescents and youth living with HIV-1. Age-specific approaches might play an important role in interventions targeting HSV-2 infection., Competing Interests: No Conflict of Interest is declared, (Copyright (c) 2020 Rashid Madebe, Ireen Kiwelu, Arnold Ndaro, Filbert Francis, Vito Baraka, Zahra Theilgaard, Terese Katzenstein.)
- Published
- 2020
- Full Text
- View/download PDF